Jessica Peace Bytautas

Jessica Peace Bytautas

Auto-generated profile, based on publicly available information

Jessica Peace Bytautas

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2013 in European Journal of Human Genetics
Verified
Journal Article
Closed access
FMFiona A Miller
Fiona A Miller
RHRobin Z Hayeems
Robin Z Hayeems
JBJessica P Bytautas
Jessica P Bytautas
PBPhilippe L Bedard
Philippe L Bedard
SEScott Ernst
Scott Ernst
LSLillian L Siu
Lillian L Siu

24 June 2014 in Cancer
Verified
Journal Article
Open access
PDF file
PBPhillip S. Blanchette
Phillip S. Blanchette
ASAnna Spreafico
Anna Spreafico
FMFiona A Miller
Fiona A Miller
KCKelvin Chan
Kelvin Chan
JBJessica Bytautas Ba
Jessica Bytautas Ba
LSLillian L. Siu
Lillian L. Siu
BACKGROUND: Genomic testing in cancer (GTC) characterizes genes that play an important role in the development and growth of a patient's cancer. This form of DNA testing is currently being studied for its ability to guide cancer therapy. The objective of the current study was to describe patients' knowledge, attitudes, and expectations toward GTC.METHODS: A 42‐item self‐administered GTC questionnaire was developed by a multidisciplinary group and patient pretesting. The questionnaire was distributed to patients with advanced cancer who were referred to the Princess Margaret Cancer Center for a phase 1 clinical trial or GTC testing.RESULTS: Results were reported from 98 patients with advanced cancer, representing 66% of the patients surveyed. Seventy‐six percent of patients were interested in learning more about GTC, and 64% reported that GTC would significantly improve their cancer care. The median score on a 12‐item questionnaire to assess knowledge of cancer genomics was 8 of 12 items correct (67%; interquartile range, 7‐9 of 12 items correct [58%‐75%]). Scores were associated significantly with patients' education level (P < .0001). Sixty‐six percent of patients would consent to a needle biopsy, and 39% would consent to an invasive surgical biopsy if required for GTC. Only 48% of patients reported having sufficient knowledge to make an informed decision to pursue GTC whereas 34% of patients indicated a need for formal genetic counseling.CONCLUSIONS: Patients with advanced cancer are motivated to participate in GTC. Patients require further education to understand the difference between somatic and germline mutations in the context of GTC. Educational programs are needed to support patients interested in pursuing GTC. Cancer 2014;120:3066–3073. © 2014 American Cancer Society.

6 June 2019 in JMIR Medical Informatics
Verified
Journal Article
Open access
MDMark J Dobrow
Mark J Dobrow
JBJessica P Bytautas
Jessica P Bytautas
STSukirtha Tharmalingam
Sukirtha Tharmalingam
SHSimon Hagens
Simon Hagens
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: As the availability of interoperable electronic health records (iEHRs) or Health Information Exchanges (HIEs) continues to increase, there is greater need and opportunity to assess the current evidence base on what works and what doesn't regarding the adoption, use and impact of iEHRs. Objective: The purpose of this project is to assess the international evidence base on the adoption, use and impact of iEHRs. Methods: We conducted a systematic review, searching multiple databases (MEDLINE, EMBASE and CINAHL) with supplemental searches conducted in Google Scholar and grey literature sources (Google, greylit.org and opengrey.eu). All searches were conducted in January/February 2017. Articles were eligible for inclusion if they were published in English, from 2006-2017, and were either an original research study or literature review. Articles needed to focus on (i) iEHRs/HIEs, (ii) across multiple health care settings, and address (iii) the adoption/use of iEHRs, and (iv) the evaluation of their impact/effectiveness. Results: We included 130 articles in the synthesis (113 empirical studies; 17 reviews), with the majority focused on the United States (68%). The empirical studies focused on a wide range of health care settings, with the three most prevalent settings studied including acute care (52%), primary care (39%), and emergency departments (30%). We identified 29 distinct measurement items in the 113 empirical studies that were linked to 522 specific measurement outcomes. Productivity and quality were the two evaluation dimensions that received the most attention, accounting for 14 of 29 (48%) measurement items and 306 of 522 (59%) measurement outcomes identified. Overall, the majority of the 522 measurement outcomes were positive (57%). We also identified 17 reviews on iEHR use/impact, six that focused on barriers/facilitators to adoption/implementation, and 11 focused on benefits/impacts, with the more recent reviews finding little generalizable evidence of benefit/impact. Conclusions: This review captures the status of an evolving and active field focused on the use/impact of iEHRs. While the overall findings suggest many positive impacts, the quality of the empirical research is variable. When broken down by specific measurement item, the results directed attention both to measurement outcomes that were consistently positive and others that were mostly negative or equivocal.

17 March 2010 in European Journal of Human Genetics
Verified
Journal Article
Closed access
FMFiona A Miller
Fiona A Miller
RHRobin Zoe Hayeems
Robin Zoe Hayeems
JBJessica Peace Bytautas
Jessica Peace Bytautas

1 June 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
FWF. Webster
F. Webster
APA.V. Perruccio
A.V. Perruccio
RJR. Jenkinson
R. Jenkinson
SJS. Jaglal
S. Jaglal
ESE. Schemitsch
E. Schemitsch
ADA.M. Davis
A.M. Davis

1 May 2017 in The Journal of Pediatrics
Verified
Journal Article
Closed access
RHRobin Hayeems
Robin Hayeems
FMFiona A. Miller
Fiona A. Miller
CBCarolyn J. Barg
Carolyn J. Barg
YBYvonne Bombard
Yvonne Bombard
JCJune C. Carroll
June C. Carroll
AGAstrid Guttmann
Astrid Guttmann